Indications
Tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Composition
- Active substance
- tolvaptan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Tolvaptan Accord
- Active substance
- tolvaptan
- ATC code
- C03XA01
- Therapeutic area
- Inappropriate ADH Syndrome
- Marketing authorisation holder
- Accord Healthcare S.L.U.
- Status
- Authorised
- EMA product number
- EMEA/H/C/005961